Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Plasma cell disorders

Serum proteomic profiling reveals MTA2 and AGO2 as potential prognostic biomarkers associated with disease activity and adverse outcomes in multiple myeloma

Dollapak Apipongrat, Sittiruk Roytrakul, Kannadit Prayongratana, Mongkon Charoenpitakchai, Kamphon Intharanut, Chonlada Laoruangroj, Panachai Silpsamrit, Oytip Nathalang

published 01 Dec 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Prevalence of corneal findings and their interrelation with hematological findings in monoclonal gammopathy

Mohammad Al Hariri, Markus Munder, Walter Lisch, Alexander K. Schuster, Eva-Marie Fehr, Björn Jacobi, Alexander Desuki, Andreas Kreft, Adrian Gericke, Norbert Pfeiffer, Joanna Wasielica-Poslednik

published 31 Oct 2022

Loading metrics information...

Metrics unavailable. Please check back later.

LTβR overexpression promotes plasma cell accumulation

Jessica A. Kotov, Ying Xu, Nicholas D. Carey, Jason G. Cyster

published 04 Aug 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Usability of German hospital administrative claims data for healthcare research: General assessment and use case of multiple myeloma in Munich university hospital in 2015–2017

Amal AlZahmi, Irena Cenzer, Ulrich Mansmann, Helmut Ostermann, Sebastian Theurich, Tobias Schleinkofer, Karin Berger

published 28 Jul 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort

Nadjoua Maouche, Bhuvan Kishore, Zara Bhatti, Supratik Basu, Farheen Karim, Sharadha Sundararaman, Freya Collings, Bing Tseu, Heather Leary, Noel Ryman, Udaya Reddy, Grant D. Vallance, Jaimal Kothari, Karthik Ramasamy

published 07 Jul 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Vγ9Vδ2 T cells expressing a BCMA—Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth

Xi Zhang, Yu Yang Ng, Zhicheng Du, Zhendong Li, Can Chen, Lin Xiao, Wee Joo Chng, Shu Wang

published 16 Jun 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Response rates and minimal residual disease outcomes as potential surrogates for progression-free survival in newly diagnosed multiple myeloma

Patrick Daniele, Carla Mamolo, Joseph C. Cappelleri, Timothy Bell, Alexander Neuhof, Gabriel Tremblay, Mihaela Musat, Anna Forsythe

published 12 May 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients

Jillian C. Thompson, Yi Ren, Kristi Romero, Meagan Lew, Amy T. Bush, Julia A. Messina, Sin-Ho Jung, Sharareh Siamakpour-Reihani, Julie Miller, Robert R. Jenq, Jonathan U. Peled, Marcel R. M. van den Brink, Nelson J. Chao, Mark G. Shrime, Anthony D. Sung

published 04 May 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Radotinib inhibits multiple myeloma cell proliferation via suppression of STAT3 signaling

Sook-Kyoung Heo, Eui-Kyu Noh, Hye Jin Seo, Yoo Jin Lee, SuJin Koh, Young Joo Min, Yunsuk Choi, Jae-Cheol Jo

published 03 May 2022

Loading metrics information...

Metrics unavailable. Please check back later.

A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001)

Anshul Agarwal, Aakanksha Khandelwal, Kavita Pal, Naveen Kumar Khare, Vishal Jadhav, Murarilal Gurjar, Sachin Punatar, Anant Gokarn, Avinash Bonda, Lingaraj Nayak, Sadhana Kannan, Vikram Gota, Navin Khattry, Indraneel Mittra

published 04 Feb 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM

Hyunkyung Park, Ja Min Byun, Sung-Soo Yoon, Youngil Koh, Sock-Won Yoon, Dong-Yeop Shin, Junshik Hong, Inho Kim

published 27 Jan 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients

Faouzi Djebbari, Alexandros Rampotas, Fotios Panitsas, Wen Yuen Lim, Charlotte Lees, Ismini Tsagkaraki, Ana Rita Gomes, Steve Prideaux, Lucia Chen, Catherine Prodger, Akhil Khera, Nicola Gray, Lauren Ellis, Gina Sangha, Toby A. Eyre, Sally Moore, Jaimal Kothari, Karthik Ramasamy

published 11 Jan 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Ultrasonographic characteristics of major salivary glands in anti-centromere antibody-positive primary Sjögren’s syndrome

Hong Ki Min, Se-Hee Kim, Youngjae Park, Kyung-Ann Lee, Seung-Ki Kwok, Sang-Heon Lee, Hae-Rim Kim

published 03 Nov 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Plasma cell disorders

You can change these options by clicking profile then "Alerts and Notifications"